nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice
|
Akeus, Paulina |
|
2014 |
63 |
8 |
p. 807-819 |
artikel |
2 |
Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy
|
Smith, David A. |
|
2014 |
63 |
8 |
p. 787-796 |
artikel |
3 |
B7-H1 signaling is integrated during CD8+ T cell priming and restrains effector differentiation
|
Gibbons, Rachel M. |
|
2014 |
63 |
8 |
p. 859-867 |
artikel |
4 |
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells
|
Kosaka, Akemi |
|
2014 |
63 |
8 |
p. 847-857 |
artikel |
5 |
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
|
Bruserud, Øystein |
|
2014 |
63 |
8 |
p. 757-777 |
artikel |
6 |
Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine
|
Hu, Yinin |
|
2014 |
63 |
8 |
p. 779-786 |
artikel |
7 |
Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy
|
Brehm, Claudia |
|
2014 |
63 |
8 |
p. 821-833 |
artikel |
8 |
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy
|
Park, Jungsun |
|
2014 |
63 |
8 |
p. 835-845 |
artikel |
9 |
Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
|
Kobayashi, Masanori |
|
2014 |
63 |
8 |
p. 797-806 |
artikel |